Skip to content

A randomized blind parallel controlled clinical study of acupuncture combined with amiodarone in the treatment of rapid paroxysmal atrial fibrillation

A randomized blind parallel controlled clinical study of acupuncture combined with amiodarone in the treatment of rapid paroxysmal atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000589
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

auricular fibrillation

Interventions

Constant acupunture therapy group :Amiodarone treatment was combined with constant acupuncture once daily for a total of 5 days
acupunture therapy group:Amiodarone treatment was combined with acupuncture once daily for a total of 5 days

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of traditional Chinese and Western medicine for rapid paf (palpitation disease); 2) age 18 to 80 years gender limitation; 3) did not receive acupuncture treatment within 3 months; 4) agreed to participate in clinical trial observation and is willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Those who do not meet the above diagnostic criteria and inclusion criteria; 2) persistent and permanent atrial fibrillation; 3) hemodynamic instability such as hypotension syncope acute pulmonary edema or cardiogenic shock due to the onset of atrial fibrillation; 4) with severe life-threatening primary diseases including cardiac vessels cerebrovascular vessels liver kidney and hematopoietic system and severe cardiac dysfunction (ef & lt; 40%); 5) Patients with cardiomyopathy chronic pulmonary heart disease preexcitation syndrome mitral valve prolapse congenital heart disease hyperthyroidism diabetes mellitus and other arrhythmia diseases; 6) pregnant or lactating women Or combined with a psychosis Or have contraindications for acupuncture treatment Or allergic or taboo to iodine and amiodarone Or skin allergy to ECG monitoring electrodes; 7) have participated in or using other clinical intervention options affecting the trial study.

Design outcomes

Primary

MeasureTime frame
The time of atrial fibrillation;major adverse cardiovas-cular and cerebrovascular events;

Secondary

MeasureTime frame
Atrial fibrillation load;Index of heart rate variability;Traditional Chinese medicine syndrome points;The Anxiety and Depression Scale;the Atrial Fibrillation Effect on Quality-of-Life;LAD and LVEF;ventricular rate;Changes in cardiac function and inflammatory indicators;Transoversion success rate of atrial fibrillation;Antiarrhythmic drug use status;

Countries

China

Contacts

Public ContactSiyu Qiao

Department of Cardiology Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

1934131@163.com13917412133

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026